Evidence map›Paper›PMID 42085487›Full record

ArticlePLOS digital health2026

Identifying factors associated with vaping cessation in young adults: A machine learning and XAI approach.

Poolakkad S Satheeshkumar, Ian Lango, Swarnali Zafo, Mikaiel Ebanks, Rahul Kumar Das, Kit Wai Cheung, Roberto Pili, Supriya D Mahajan

Abstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Poolakkad S SatheeshkumarDepartment of Medicine, Division of Hematology and Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
Ian LangoUniversity at Buffalo, Buffalo, New York, United States of America.
Swarnali ZafoJacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States of America.
Mikaiel EbanksUniversity at Buffalo, School of Public Health and Health Professions, Buffalo, New York, United States of America.
Rahul Kumar DasDepartment of Medicine, Division of Allergy, Immunology & Rheumatology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
Kit Wai CheungDepartment of Medicine, Division of Allergy, Immunology & Rheumatology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
Roberto PiliDepartment of Medicine, Division of Hematology and Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
Supriya D MahajanDepartment of Medicine, Division of Allergy, Immunology & Rheumatology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.ORCID https://orcid.org/0000-0002-5298-6962

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The public health impact of vaping in the United States reflects a complex balance of potential benefits and emerging risks, as e‑cigarettes may reduce exposure to toxic combustion byproducts and support adult smoking cessation, yet growing evidence links vaping to respiratory and cardiovascular harm and youth uptake remains concerning, with 38.4% of adolescent users in 2024 reporting habitual use. To inform the optimal use of predictive technologies in cessation efforts, this study sought to characterize cessation‑related behaviors and attitudes among young adult vapers and evaluate machine learning and explainable AI methods for predicting quit attempts and cessation success. A social media-based survey captured behavioral, contextual, and demographic factors, and cessation was defined as self‑reported abstinence from all vaping products for at least 30 days. Predictors were identified using forward selection and backward elimination, and data were split into training and testing sets. Linear models (LASSO, ridge regression, elastic net) and nonlinear models (random forest, support vector machine) were trained and evaluated using AUC and Brier scores. Linear models demonstrated the strongest overall performance: LASSO achieved AUCs of 0.89 (training) and 0.91 (testing), ridge regression 0.88 and 0.93, and elastic net 0.91 for both sets. Nonlinear models showed signs of overfitting, with random forest achieving 0.99 in training but only 0.70 in testing, and SVM achieving 0.89 and 0.72. Key predictors included age, environmental triggers, vaping frequency, sex, and long‑term behavioral outlook. Individuals under 25 showed greater vulnerability to continued use, environmental cues, especially social exposure, were strongly associated with relapse, and erratic vaping patterns predicted lower cessation success. While these models highlight behavioral and contextual factors that may influence cessation, findings should be interpreted as exploratory given the cross‑sectional design and sample characteristics. Larger, longitudinal studies are needed to validate these insights and clarify the potential of predictive modeling to inform targeted public health interventions.

Identifiers

PMID42085487
PMCPMC13143109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.